The trademark Tyrogene was filed by Heinz Kofler, a national of the Republic of Austria (the "Applicant"). The application was published for oppositions on March 25, 2021, and received one opposition filed on March 31, 2021 by Genzyme Corporation on Likelihood of confusion. the opponent was represented by CASALONGA ALICANTE, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 31, 2021
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003143562 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on May 2, 2023 by the EUIPO.
Goods And Services
The mark was filed in class 42 with following description of goods:
Genetic research
Research and development services in the field of immunology
Medical research
Medical research laboratory services
Medical and pharmacological research services
Provision of information and data relating to medical and veterinary research and development
Research on the subject of pharmaceuticals
Biological research, clinical research and medical research
Scientific research for medical purposes
Pharmaceutical research services
Pharmaceutical research and development
Research and development in the field of diagnostic preparations
Scientific research
Clinical research
Design and development of medical diagnostic apparatus.
The mark was filed in class 44 with following description of goods: